EN
TR
Effects of Grayanotoxin-III on different cell lines: in vitro ischemia model
Abstract
Grayanotoxins (GTXs) are natural products and are mostly found in plants of the Ericaceae family, especially in the Rhododendron. With their ability to bind to voltage-gated sodium channels, they keep these channels constantly active and cause tissue damage. However, despite this feature, the use of Rhododendron leaves or its secondary products as an alternative product is especially common in Turkey. This study aims to evaluate the possible dose-related effects of GTX-III in ischemia-induced in vitro cell models. Within the scope of the study, an ischemia model was established in two different cell lines (H9c2 and Cos-7) and treated with various concentrations of GTX-III. In this context, cell viability, cytotoxicity, apoptosis and necrosis were examined. In the results of MTT, a significant decrease (+p < 0.05) in cell viability was observed in all GTX-III concentrations in H9c2 cells compared to the control, while a significant difference (+p < 0.05) was observed in Cos-7 cells, especially at the 24th hour. LDH cytotoxicity was increased in a dose-dependent manner in both cell models. It was concluded that GTX-III caused apoptosis, and reduced cell viability in ischemia models; however, promoted cell proliferation in healthy cells. Based on the literature review, this study is the first to document the cytotoxic properties and apoptotic potential of GTX-III in an in vitro cell culture ischemia model. Our findings support the usage of GTX-III, however it should be remembered that the dose needs to be verified before being used medically.
Keywords
References
- Abdel Wahab, S.I., Abdul, A.B., Alzubairi, A.S., Mohamed Elhassan, M., Mohan, S. (2009). In vitro ultramorphological assessment of apoptosis induced by zerumbone on (HeLa). Journal of Biomedicine and Biotechnology, 2009. https://doi.org/10.1155/2009/769568
- Aliyev, F., Türkoğlu, C., Çeliker, C., Firatli, I., Alici, G., & Uzunhasan, I. (2009). Chronic mad honey intoxication syndrome: a new form of an old disease?. Europace, 11(7), 954-956. https://doi.org/10.1093/europace/eup126
- Argun, M., Üzüm, K., Sönmez, M.F., Özyurt, A., Karabulut, D., Soyersarıca, Z., ... & Narin, N. (2016). Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats. Anatolian Journal of Cardiology, 16(4), 234. https://doi.org/10.5152/akd.2015.6185
- Bilir, E.K., Tutun, H., Sevin, S., Kısmalı, G., & Yarsan, E. (2018). Cytotoxic effects of Rhododendron ponticum L. extract on prostate carcinoma and adenocarcinoma cell line (DU145, PC3). Kafkas Üniversitesi Veteriner Fakültesi Dergisi, 24(3). https://doi.org/10.9775/kvfd.2017.19219
- Brown, B.S., Akera, T., & Brody, T.M. (1981). Mechanism of grayanotoxin III-induced afterpotentials in feline cardiac Purkinje fibers. European Journal hf Pharmacology, 75(4), 271-281. https://doi.org/10.1016/0014-2999(81)90554-9
- Choo, Y.K., Kang, H.Y., & Lim, S.H. (2008). Cardiac problems in mad-honey intoxication. Circulation Journal, 72(7), 1210-1211. https://doi.org/10.1253/circj.72.1210
- Condreay, J.P., Witherspoon, S.M., Clay, W.C., & Kost, T.A. (1999). Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proceedings of the National Academy of Sciences, 96(1), 127 132. https://doi.org/10.1073/pnas.96.1.127
- Doğanyiğit, Z., Silici, S., Demirtaş, A., Kaya, E., & Kaymak, E. (2019). Determination of histological, immunohistochemical and biochemical effects of acute and chronic grayanotoxin III administration in different doses in rats. Environmental Science and Pollution Research, 26(2), 1323-1335. https://doi.org/10.1007/s11356-018-3700-9
Details
Primary Language
English
Subjects
Plant Biochemistry, Structural Biology
Journal Section
Research Article
Early Pub Date
July 31, 2023
Publication Date
August 27, 2023
Submission Date
November 30, 2022
Acceptance Date
June 20, 2023
Published in Issue
Year 2023 Volume: 10 Number: 3
APA
Akbay Çetin, E., & Özenirler, Ç. (2023). Effects of Grayanotoxin-III on different cell lines: in vitro ischemia model. International Journal of Secondary Metabolite, 10(3), 370-384. https://doi.org/10.21448/ijsm.1212761
AMA
1.Akbay Çetin E, Özenirler Ç. Effects of Grayanotoxin-III on different cell lines: in vitro ischemia model. Int. J. Sec. Metabolite. 2023;10(3):370-384. doi:10.21448/ijsm.1212761
Chicago
Akbay Çetin, Esin, and Çiğdem Özenirler. 2023. “Effects of Grayanotoxin-III on Different Cell Lines: In Vitro Ischemia Model”. International Journal of Secondary Metabolite 10 (3): 370-84. https://doi.org/10.21448/ijsm.1212761.
EndNote
Akbay Çetin E, Özenirler Ç (August 1, 2023) Effects of Grayanotoxin-III on different cell lines: in vitro ischemia model. International Journal of Secondary Metabolite 10 3 370–384.
IEEE
[1]E. Akbay Çetin and Ç. Özenirler, “Effects of Grayanotoxin-III on different cell lines: in vitro ischemia model”, Int. J. Sec. Metabolite, vol. 10, no. 3, pp. 370–384, Aug. 2023, doi: 10.21448/ijsm.1212761.
ISNAD
Akbay Çetin, Esin - Özenirler, Çiğdem. “Effects of Grayanotoxin-III on Different Cell Lines: In Vitro Ischemia Model”. International Journal of Secondary Metabolite 10/3 (August 1, 2023): 370-384. https://doi.org/10.21448/ijsm.1212761.
JAMA
1.Akbay Çetin E, Özenirler Ç. Effects of Grayanotoxin-III on different cell lines: in vitro ischemia model. Int. J. Sec. Metabolite. 2023;10:370–384.
MLA
Akbay Çetin, Esin, and Çiğdem Özenirler. “Effects of Grayanotoxin-III on Different Cell Lines: In Vitro Ischemia Model”. International Journal of Secondary Metabolite, vol. 10, no. 3, Aug. 2023, pp. 370-84, doi:10.21448/ijsm.1212761.
Vancouver
1.Esin Akbay Çetin, Çiğdem Özenirler. Effects of Grayanotoxin-III on different cell lines: in vitro ischemia model. Int. J. Sec. Metabolite. 2023 Aug. 1;10(3):370-84. doi:10.21448/ijsm.1212761